HiberCell HiberCell is a company that focuses on therapeutically modulating the biology and mechanisms of tumor dormancy. | PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. | Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. | |
Founding Date | Founding Date 2019 | Founding Date 2014 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations New York, US HQ Roseville, US | Locations Paris, FR HQ Évry, FR | Locations Newark, US HQ |
Employees | Employees 264% decrease | Employees 14 | Employees 6343% increase |
Funding | |||
Latest funding round | Latest funding round $ 67.4m (almost 5 years ago) | Latest funding round $ 3m (almost 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 128.2m | Total funding raised $ 3m | Total funding raised $ 82.4m |
PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.
View companyRain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View company